Hafiz Saeed offers Americans storm aid

Islamabad, October 31: A Pakistani militant leader with a $10 million US bounty on his head has offered aid to Americans hit by superstorm Sandy.

Hafiz Saeed says his organization, Jamaat-ud-Dawa, is prepared to send volunteers, medicine and food if allowed by the United States.

Saeed said in a written statement Tuesday that it is a religious duty under Islam to help Americans affected by the storm, even if the US has put a bounty on his head.

The US offered $10 million earlier this year for information leading to Saeed's arrest or conviction. He founded Lashkar-e-Taiba, a militant group blamed for attacks in India's city of Mumbai in 2008 that killed over 160 people.

Jamaat-ud-Dawa is believed to be a front for Lashkar-e-Taiba, which was banned by the Pakistani government.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments